Skip to Content
Merck
  • Microarray-based multiplexed scanometric immunoassay for protein cancer markers using gold nanoparticle probes.

Microarray-based multiplexed scanometric immunoassay for protein cancer markers using gold nanoparticle probes.

Analytical chemistry (2009-10-31)
Dongwoo Kim, Weston L Daniel, Chad A Mirkin
ABSTRACT

We report the use of electroless gold deposition as a light scattering signal enhancer in a multiplexed, microarray-based scanometric immunoassay using gold nanoparticle probes. The use of gold development results in greater signal enhancement than the typical silver development, and multiple rounds of metal development were found to increase the resulting signal compared to one development. Using these conditions, the assay was capable of detecting 300 aM (approximately 9000 copies) of prostate specific antigen in buffer and 3 fM in 10% serum. Additionally, the highly selective detection of three protein cancer markers at low picomolar concentrations in buffer and 10% serum was demonstrated. The use of gold deposition may have significant utility in scanometric detection schemes and broader clinical and research applications.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Prostate Specific Antigen from human semen, buffered aqueous solution
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Hydroxylamine hydrochloride, ReagentPlus®, 99%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Gold(III) chloride trihydrate, ≥99.9% trace metals basis
SKU
Pack Size
Availability
Price
Quantity